Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

RTTNews | 612 hari yang lalu
Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

(RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling select Levetiracetam in Sodium Chloride Injection in the United States citing mislabeling of infusion bag, according to the U.S. Food and Drug Administration.

The recall involves one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level.

The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Both Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL and Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL are indicated for adjunct therapy in adults with select seizure types when oral administration is temporarily not feasible.

When administered the mislabeled product, the patient could receive double the dose of intravenous levetiracetam than intended as the infusion bag is labelled as 500 mg/100 mL but actually contains 1,000 mg/100 mL dose. Such patients are likely to experience adverse events, leading to immediate and serious side effects. These include hypersensitivity reactions, liver injury, hematological toxicity, somnolence, fatigue, dizziness, coordination difficulties, agitation, aggression, depressed level of consciousness, respiratory depression, and coma.

The FDA noted that patients receiving high doses of levetiracetam by rapid intravenous infusion for the treatment of status epilepticus would be most at risk for severe adverse events.

However, Dr. Reddy's has not received any reports of adverse events related to the recalled product so far.

The recall involves Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, packaged in single-dose infusion bags with an aluminum overwrap, 10 single-dose bags packed in a carton.

The mislabelled bags come with NDC numbers 43598-635-52 and 43598-636-52, with Lot Number A1540076 and Expiration Date of 08/2026. The carton holds NDC number 43598-636-10. The batch was distributed nationwide between November 4, 2024, and November 6, 2024, to wholesalers.

Dr. Reddy's is notifying its distributors and customers to arrange for return of any recalled product. Wholesalers, distributors, hospitals, and pharmacies with an existing inventory of the impacted lot are asked to stop use and distribution and quarantine the product immediately for return/replacement.

Dr. Reddy's last year had called back six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level, due to powder discoloration in some packets leading to decreased potency.

For More Such Health News, visit rttnews.com

baca selengkapnya
Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.
RTTNews | 936 hari yang lalu
Thai GDP Growth Accelerates

Thai GDP Growth Accelerates

Thailand's economic growth accelerated in the third quarter on strong investment and exports, official data revealed on Monday. Gross domestic product posted an annual expansion of 2.9 percent in the third quarter, the National Economic and Social Development Council, or NESDC said.
RTTNews | 1 jam 23 menit yang lalu
European Shares Seen Flat To Higher At Open

European Shares Seen Flat To Higher At Open

European stocks are seen opening flat to slightly higher on Monday as oil prices extended declines from last week, helping ease concerns over inflation and potential interest-rate hikes.
RTTNews | 3 jam 7 menit yang lalu
Indian Shares Surge On FII Flows

Indian Shares Surge On FII Flows

Indian shares were notably higher on Monday as falling oil prices helped ease concerns over inflation and India's import bill.
RTTNews | 4 jam 3 menit yang lalu
Australian Market Maintains Early Losses In Mid-market

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintaining its early losses in mid-market trading on Monday, extending the losses in the previous two sessions, following the mixed cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is falling well below the 9,100.00 level, with weakness in mining stocks partially offset by gains in technology, energy and financial stocks.
RTTNews | 5 jam 17 menit yang lalu
Asian Markets Trade Mostly Lower

Asian Markets Trade Mostly Lower

Asian stock markets are trading mostly lower on Monday, following the mixed cues from Wall Street on Friday, on weakness in semiconductor and technology stocks in Taiwan, South Korea and Japan which mirrored their peers on tech-heavy Nasdaq. Uncertainty and prolonged stalemate in the Middle East conflict is also weighing on market sentiment and raising global inflationary concerns.
RTTNews | 5 jam 43 menit yang lalu
Indian Shares Seen Higher At Open

Indian Shares Seen Higher At Open

Indian shares are seen opening a tad higher on Monday as oil prices extended declines from last week, helping ease concerns over inflation and India's import bill.
RTTNews | 6 jam 13 menit yang lalu